Boriana Tzvetkova
Associate Scientist, Analytical R&D
Meet the rest of our
see all team members
Bo Cumbo
President and Chief Executive Officer, Solid Biosciences
Andrew Geall, Ph.D.
Co-Founder and Chief Development Officer, Replicate Bioscience
Michael MacLean
Chief Financial Officer and Chief Business Officer, Avidity Biosciences
Yasser (Yas) El-Gamal, J.D.
Senior Vice President, Legal Affairs and Chief Intellectual Property Counsel
Daniel J. Rader, M.D.
Chair, Department of Genetics, University of Pennsylvania
J. Keith Joung, M.D., Ph.D.
Robert B. Colvin, M.D. Endowed Chair in Pathology and Pathologist, Massachusetts General Hospital; Professor of Pathology, Harvard Medical School
Krishna Yeshwant, M.D.
Managing Partner, GV
Leslie Stolz, Ph.D.
Senior Vice President, Regulatory Affairs
Nia Tatsis, Ph.D.
Executive Vice President and Chief Regulatory and Quality Officer, Vertex Pharmaceuticals
Lonnel Coats
Chief Executive Officer and Director, Lexicon Pharmaceuticals
Eugene Braunwald, M.D.
Distinguished Hersey Professor of Medicine at Harvard Medical School
Issi Rozen
Venture Partner, GV
Jodie Morrison
Chief Executive Office and Director, Q32 Bio Inc.
Barry Ticho, M.D., Ph.D.
Chief Medical Officer, Stoke Therapeutics
Troy Lister, Ph.D.
Chief Scientific Officer
Fred Fiedorek, M.D.
Chief Medical Officer
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Kiran Musunuru, M.D., Ph.D.
Professor of Cardiovascular Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania
Jason Politi
Chief Technical Operations Officer
Burt Adelman, M.D.
Chairman of the Board; former EVP and Chief Medical Officer, Dyax
Allison Dorval
Chief Financial Officer
Anthony Philippakis, M.D., Ph.D.
Chief Data Officer, Broad Institute of MIT and Harvard
Joan Nickerson
Chief Administrative Officer
Andrew Ashe, J.D.
President, Chief Operating Officer and General Counsel
